arithmos— AI-powered custom index builder. You’re viewing a shared index.
Index
mRNA Platform Index
official“An index of biotech companies built around mRNA platforms — vaccines, oncology, rare disease, and protein replacement therapies.” — by Hiroshi 'Hiro' Tanaka
built · 2026-04-30 21:38·rebalance · semiannual·next run · 2026-10-30
backtest · S&P 500 (SPX)·range
CAGR—
Annual vol—
Sharpe—
Sortino—
Max drawdown—
Best year—
Worst year—
risk-free raterf = 4.50%
vs S&P 500 (SPX) · 1M—
vs S&P 500 (SPX) · 1Y—
vs S&P 500 (SPX) · 2Y—
vs S&P 500 (SPX) · 3Y—
vs S&P 500 (SPX) · 5Y—
vs S&P 500 (SPX) · 10Y—
no backtest data
sharpe ratio
| ticker | weight | YTD | 1Y | 3Y | 5Y | 10Y |
|---|---|---|---|---|---|---|
| MRNA | 12.5% | — | — | — | — | — |
| BNTX | 12.5% | — | — | — | — | — |
| PFE | 12.5% | — | — | — | — | — |
| BEAM | 12.5% | — | — | — | — | — |
| VRTX | 12.5% | — | — | — | — | — |
| ARCT | 12.5% | — | — | — | — | — |
| TBPH | 12.5% | — | — | — | — | — |
| PSTX | 12.5% | — | — | — | — | — |
| weighted | 100% | — | — | — | — | — |
attribution factsheet
holdings · 8
click a row to drill in ↗NameAllocationRationale
MRNAModernaHealthcare12.50%Largest pure-play mRNA pipeline beyond COVID-19.BNTXBioNTechHealthcare12.50%Pfizer-partnered platform with extensive oncology pipeline.PFEPfizerHealthcare12.50%BioNTech mRNA partner and BNT-derived oncology programs.BEAMBeam TherapeuticsHealthcare12.50%mRNA-LNP delivery for in-vivo base editing.VRTXVertex PharmaceuticalsHealthcare12.50%mRNA-edited cell therapy partnership for type 1 diabetes.ARCTArcturus TherapeuticsHealthcare12.50%Self-amplifying mRNA platform partnered with CSL.TBPHTheravance BiopharmaHealthcare12.50%Inhaled mRNA platform with Innoviva backing.PSTXPoseida TherapeuticsHealthcare12.50%Genetic medicines using non-viral mRNA delivery (Astellas-acquired).
weighting · equal
rebalance · semiannual
